| Literature DB >> 30444919 |
Wen Jie Wang1, Li Wei Zhang2, Shun Yi Feng1, Jie Gao1, Yong Li1.
Abstract
Sequential organ failure assessment (SOFA) score is commonly used to determine disease severity and predict prognosis in critically ill patients. However, the prognostic value of SOFA after acute paraquat (PQ) poisoning remains unclear. This meta-analysis aimed to study the capability of SOFA to predict mortality in patients with PQ poisoning. Databases that included PubMed, Embase, Web of Science, ScienceDirect, Embase, and Cochrane Library were searched through May 2018. Six studies involving 946 patients were included in the meta-analysis. Study-specific odds ratios (ORs) and 95% confidence intervals (CIs) were calculated, and then ORs with 95% CIs were pooled for the estimation of the prognostic role of SOFA in patients with PQ poisoning. Results showed that higher SOFA in patients with PQ poisoning was related to severe mortality (OR = 8.14, 95%CI 4.26-15.58, p<0.001). The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic OR, and area under the curve were 72% (95%CI 0.65-0.79), 75% (95%CI 0.65-0.83), 2.9 (95%CI 2.0-4.1), 0.37 (95%CI 0.28-0.41), 8 (95%CI 4-14), and 0.79 (95%CI 0.76-0.83), respectively. No evidence of publication bias was detected by funnel plot analysis and formal statistical tests. Sensitivity analyses showed no important differences in the estimates of effects. The high SOFA score (8.1-fold) was associated with severe mortality in patients with PQ poisoning.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30444919 PMCID: PMC6239328 DOI: 10.1371/journal.pone.0207725
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Risk of bias and applicability concerns.
Characteristics of included studies.
| First author | Publication | Study | Sample size | Mortality (%) | Cut-off value | SOFA | Blood PQ level | Time from ingestion to arrival (h) | Treatment protocol | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Survivor | Non-survivor | Survivor | Non-survivor | Survivor | Non-survivor | |||||||
| 2015 | Retrospective | 118 | 45.76 | 3 | 2.21±0.76 | 3.31±1.06 | NA | NA | NA | NA | GL, HP, MP, CP, glutathione | |
| 2015 | Prospective | 97 | 42.27 | 2.5 | 2 | 5 | 0.1 | 0.8 | 14.3±5.5 | 14.1±5.9 | GL, HP,MP, glutathione, vitamin C | |
| 2016 | Retrospective | 219 | 80.37 | 3 | 1.6±1.9 | 3.5±2.7 | NA | NA | NA | NA | GL, HP | |
| 2015 | Prospective | 177 | 37.85 | 9 | NA | NA | NA | NA | NA | NA | GL, HP, MP, CP | |
| 2016 | Prospective | 148 | 70.95 | 0.5 | 0.98±0.72 | 1.34±1.29 | 0.91±0.38 | 2.28±1.52 | 4.28±2.44 | 7.86±3.02 | GL, HP, MP, glutathione, vitamin C | |
| 2012 | Retrospective | 187 | 54.01 | 3 | 2±2 | 4±2 | 1.4±2.0 | 7.6±6.1 | 19.1±26.9 | 8.7±12.9 | GL, HP, MP, CP | |
NA = not available. SOFA = sequential organ failure assessment; PQ = paraquat; GL = gastric lavage HP = hemoperfusion; MP = methylprednisolone; CP = cyclophosphamide
*Continuous variable is presented as means ± SD or median (interquartile range) and categorical variable is presented as no. (%).
Fig 2Forest plot for the association of SOFA and mortality.
Fig 3Risk of bias and applicability concerns.
Fig 4Summary ROC curve for the 6 included studies.
Numbers in brackets are 95% CIs. AUC = area under ROC curve, SENS = sensitivity, SPEC = specificity.
Meta-regression analysis of potential sources of heterogeneity.
| Heterogeneity factors | Coefficient | SE | Z | P-value | 95% CI (lower limit, upper limit) |
|---|---|---|---|---|---|
| 0.767 | 0.815 | 0.94 | 0.519 | −9.593, 11.128 | |
| 2.264 | 0.813 | 2.79 | 0.219 | −8.061, 12.588 | |
| 1.842 | 0.651 | 2.83 | 0.216 | −6.426, 10.111 | |
| −1.864 | 1.299 | −1.44 | 0.387 | −18.367, 14.639 |
CI = confidence intervals, SE = standard error.
Fig 5Funnel plot of the publication bias test.
(A)Begg’s test; and (B) Egger’s test.
Fig 6Sensitivity analysis of the relationship between SOFA and mortality.